Login | Create a free account

Johnson& Johnson sells more than $500 million worth of its COVID-19 vaccine in third quarter

Johnson & Johnson said Tuesday that it sold more than $500 million worth of its COVID-19 vaccine during the third quarter, surpassing what most experts anticipated....

read more...

Share |

Published By: UPI Business News - Tuesday, 19 October